Regencell Bioscience Holdings Limited carries a market capitalization of 2.95B, placing it among publicly traded companies globally.
| Market Cap | 2.95B |
| Enterprise Value | N/A |
Regencell Bioscience Holdings Limited's stock has declined approximately -56.32772% over the past 52 weeks. The 50-day moving average sits at 16.18, while the 200-day moving average is 21.61.
| Beta (5Y) | N/A |
| 52-Week Price Change | -56.32772% |
| 50-Day Moving Average | 16.18 |
| 200-Day Moving Average | 21.61 |
| Average Volume (20 Days) | N/A |
Regencell Bioscience Holdings Limited's most recent stock split took place on June 16, 2025 with a 1:38 split ratio.
| Last Split Date | 6/16/2025 |
| Split Ratio | 1:38 |